Cargando…
A novel naphthalimide that selectively targets breast cancer via the arylhydrocarbon receptor pathway
We report that the naphthalimide analogue 2-(2-aminophenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (NAP-6) is a highly potent and selective breast cancer targeting molecule. These effects are mediated via the aryl hydrocarbon receptor (AHR) pathway and the subsequent induction of CYP1 metabolising m...
Autores principales: | Gilbert, J., De Iuliis, G. N., McCluskey, A., Sakoff, J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438328/ https://www.ncbi.nlm.nih.gov/pubmed/32814815 http://dx.doi.org/10.1038/s41598-020-70597-8 |
Ejemplares similares
-
Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD
por: Chiba, Takahito, et al.
Publicado: (2012) -
Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR)
por: Wong, Patrick S, et al.
Publicado: (2009) -
Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy
por: Kim, Jin Taek, et al.
Publicado: (2013) -
Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor
por: Matsuda, Shun, et al.
Publicado: (2016) -
Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
por: Lim, Wonchung, et al.
Publicado: (2011)